查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1813930

美国雇主和职场药物检测市场规模、份额和趋势分析报告：按类型、产品、模式、药物、最终用途和细分预测，2025-2033 年

U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens, Post-employment), By Product, By Mode, By Drug, By End-use (IT/Finance, Manufacturing), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

预计 2024 年美国雇主和职场药物检测市场价值将达到 25.7 亿美元，到 2033 年将达到 40.1 亿美元，2025 年至 2033 年的复合年增长率为 5.2%。

这个市场的主要驱动力在于严格的职场安全法规、日益增强的药物滥用风险意识，以及各行各业日益推行的预防性筛检措施。药物检测计画被广泛实施，用于检测非法药物的存在和处方药的滥用情况，而全面的筛检通讯协定有助于遵守联邦和州政府的要求，提高生产力，并减少职场事故。

随着快速检测套组、实验室检测和口腔液体检测方法的改进，职场对职场前和随机检测的需求日益增长。数位化结果系统和自动化报告使这项流程更快、更准确，使雇主能够快速做出招募决策并更有效地监控员工。此外，多个州大麻法律的变化促使主要企业调整其检测政策，以满足合规需求和不断变化的法律标准。

根据美国成瘾中心2024年进行的全国性调查，15.3%的美国劳工承认曾在酒精影响下工作，2.9%的劳工承认曾在非法药物影响下工作。这凸显了雇主面临的持续挑战，并凸显了製定强有力的药物检测政策以保障职场安全和生产力的必要性。

患有物质使用障碍 (SUD) 的员工数量不断增加，使得职场的药物检测变得更加重要。药物滥用会导致生产力下降、缺勤率上升和盛行率上升。它还会降低员工士气，增加工作场所事故和伤害的风险，每年对美国企业造成数十亿美元的损失。这些因素预计将推动美国各地雇主和职场对药物检测服务的需求。

总体而言，美国雇主和职场药物检测市场正在经历稳定的技术创新，旨在提高速度、准确性和易用性。检测方法、数位化结果管理和分析工具的进步正在帮助雇主简化筛检流程，同时确保遵守不断变化的法规。在云端基础和人工智慧主导的分析支援下，多面板和口腔液体检测的采用，有助于检测更广泛的物质并及早发现潜在问题。这些技术创新预计将在未来几年加强职场安全计划，并支持更有效的劳动力管理。

目录

第一章调查方法与范围

第二章执行摘要

第三章美国雇主和职场药物测试市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场前景。
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国雇主和职场药物测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章美国雇主和职场药物测试市场：类型估计和趋势分析

  • 细分仪表板
  • 美国雇主与职场药物检测市场波动分析
  • 美国雇主和职场药物检测市场规模和趋势分析（按类型）（2021-2033）
  • 就业前药物测试
  • 就业后

第五章美国雇主与职场药物检测市场：产品估计与趋势分析

  • 细分仪表板
  • 美国雇主与职场药物检测市场、产品差异分析
  • 2021-2033 年美国雇主及职场药物检测市场规模及趋势分析（依产品）
  • 耗材
  • 装置
  • 快速检测装置
  • 服务

第六章美国雇主和职场药物测试市场：模式估计和趋势分析

  • 细分仪表板
  • 美国雇主与职场药物检测市场波动分析
  • 美国雇主和职场药物检测市场规模和趋势分析（按模式）（2021-2033）
  • 尿
  • 头髮
  • 口腔液体
  • 即时测试

第七章美国雇主和职场药物检测市场：药物估计和趋势分析

  • 细分仪表板
  • 美国雇主和职场药物检测市场的药物波动分析
  • 美国雇主和职场药物检测市场规模和趋势分析（按药物，2021-2033 年）
  • 酒精
  • 大麻/大麻
  • 古柯碱
  • 阿片类药物
  • 安非他命和甲基安非他命
  • LSD
  • 其他的

第八章美国雇主和职场药物测试市场：最终用途估计和趋势分析

  • 细分仪表板
  • 美国雇主和职场药物检测市场的最终用途趋势分析
  • 美国雇主与职场药物检测市场规模及趋势分析（依最终用途），2021-2033 年
  • IT/金融
  • 製造业
  • 运输
  • 建造
  • 零售和酒店
  • 卫生保健
  • 教育
  • 其他专业服务

第九章 竞争态势

  • 公司/竞争对手分类
  • 战略地图
  • 2024年企业市场分析
  • 主要认证提供者/计画所有者列表
  • 公司简介/上市公司
    • First Advantage
    • Laboratory Corporation of America Holdings（Labcorp）
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Clinical Reference Laboratory Inc.
    • Quest Diagnostics
    • Cordant Health Solutions
    • DISA Global Solutions
    • HireRight, LLC
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories
Product Code: GVR-4-68040-450-9

Market Size & Trends:

The U.S. employer and workplace drug testing market size was estimated at USD 2.57 billion in 2024 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The market is primarily driven by stringent workplace safety regulations, growing awareness of substance abuse risks, and the increasing adoption of preventive screening measures across various industries. Drug testing programs are widely implemented to detect the presence of illicit substances and misuse of prescription medications, while comprehensive screening protocols support compliance with federal and state requirements, promote productivity, and reduce workplace incidents.

The demand for pre-employment and random workplace testing is growing, supported by improvements in rapid testing kits, lab-based tests, and oral fluid testing methods. Digital result systems and automated reporting have made the process faster and more accurate, helping employers make quick hiring decisions and monitor staff more effectively. Changing cannabis laws in several states are also leading companies to adjust their testing policies to meet both compliance needs and evolving legal standards.

A national survey by American Addiction Centers in 2024 found that 15.3% of U.S. workers had worked under the influence of alcohol, while 2.9% admitted to being under the influence of illegal drugs. This shows the ongoing challenges faced by employers and highlights the need for strong drug testing policies to protect workplace safety and productivity.

The rising number of employees with substance use disorders (SUD) further increases the importance of workplace testing. Substance abuse can lead to lower productivity, more absenteeism, and higher rates of illness. It also harms employee morale and raises the risk of workplace accidents and injuries, which together cost U.S. businesses billions of dollars each year. These factors are expected to keep driving the demand for employer and workplace drug testing services across the country.

Overall, the U.S. employer and workplace drug testing market is experiencing steady innovation aimed at improving speed, accuracy, and ease of use. Advancements in testing methods, digital result management, and analytical tools are helping employers streamline screening processes while ensuring compliance with evolving regulations. The adoption of multi-panel and oral fluid testing, supported by cloud-based platforms and AI-driven analytics, is making it easier to detect a broader range of substances and identify potential issues early. These innovations are expected to strengthen workplace safety programs and support more effective workforce management in the years ahead.

U.S. Employer And Workplace Drug Testing Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. employer and workplace drug testing market on type, product, mode, drug and end-use:

  • Type Outlook (Revenue in USD Million, 2021 - 2033)
  • Pre-employment Drug Screens
  • Post-employment
  • Product Outlook (Revenue in USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
  • Mode Outlook (Revenue in USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
  • Drug Outlook (Revenue in USD Million, 2021 - 2033)
  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others
  • End-use Outlook (Revenue in USD Million, 2021 - 2033)
  • IT/Finance
  • Manufacturing
  • Transportation
  • Construction
  • Retail and Hospitality
  • Healthcare
  • Education
  • Other Professional Services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Product Segment
    • 1.2.3. Mode Segment
    • 1.2.4. Drug Segment
    • 1.2.5. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Employer and Workplace Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Employer and Workplace Drug Testing Market Type Movement Analysis
  • 4.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Pre-employment Drug Screens
    • 4.4.1. Pre-employment drug screens market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Post-employment
    • 4.5.1. Post-employment market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Employer and Workplace Drug Testing Market Product Movement Analysis
  • 5.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Rapid Testing Devices
    • 5.6.1. Rapid testing devices market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Services
    • 5.7.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Employer and Workplace Drug Testing Market Mode Movement Analysis
  • 6.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Hair
    • 6.5.1. Hair market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Oral Fluid
    • 6.6.1. Oral fluid market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Instant testing
    • 6.7.1. Instant testing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Employer and Workplace Drug Testing Market Drug Movement Analysis
  • 7.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Drug, 2021 to 2033 (USD Million)
  • 7.4. Alcohol
    • 7.4.1. Alcohol market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Cannabis/Marijuana
    • 7.5.1. Cannabis/marijuana market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Cocaine
    • 7.6.1. Cocaine market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Opioids
    • 7.7.1. Opioids testing market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Amphetamine & Methamphetamine
    • 7.8.1. Amphetamine & methamphetamine market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. LSD
    • 7.9.1. LSD market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.10. Others
    • 7.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Employer and Workplace Drug Testing Market End Use Movement Analysis
  • 8.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. IT/Finance
    • 8.4.1. IT/finance market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Manufacturing
    • 8.5.1. Manufacturing market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Transportation
    • 8.6.1. Transportation market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Construction
    • 8.7.1. Construction market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. Retail and Hospitality
    • 8.8.1. Retail and hospitality market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9. Healthcare
    • 8.9.1. Healthcare market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.10. Education
    • 8.10.1. Education surgical centers market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.11. Other Professional Services
    • 8.11.1. Other Professional Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. List of Key Certification Providers/Scheme Owners
  • 9.5. Company Profiles/Listing
    • 9.5.1. First Advantage
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Laboratory Corporation of America Holdings (Labcorp)
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Dragerwerk AG & Co. KGaA
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Bio-Rad Laboratories, Inc.
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Abbott
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Clinical Reference Laboratory Inc.
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Quest Diagnostics
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Cordant Health Solutions
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. DISA Global Solutions
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HireRight, LLC
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. OraSure Technologies, Inc.
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Psychemedics Corporation
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Omega Laboratories
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 5 U.S. employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 6 U.S. employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. employer and workplace drug testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. employer and workplace drug testing market: Type outlook key takeaways
  • Fig. 20 U.S. employer and workplace drug testing market: Type movement analysis
  • Fig. 21 Pre-employment drug screens market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Post-employment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. employer and workplace drug testing market: Product outlook key takeaways
  • Fig. 24 U.S. employer and workplace drug testing market: Product movement analysis
  • Fig. 25 Consumables market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rapid testing devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 30 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 31 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Hair market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Oral fluid market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Instant testing estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 36 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 37 Alcohol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Cannabis/marijuana market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Cocaine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Opioids estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 LSD market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. employer and workplace drug testing market: End Use outlook key takeaways
  • Fig. 45 U.S. employer and workplace drug testing market: End Use movement analysis
  • Fig. 46 IT/finance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Construction estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Retail and hospitality market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Education market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Other professional services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Market participant categorization
  • Fig. 55 U.S. employer and workplace drug testing market position analysis, 2024
  • Fig. 56 Strategic framework